<--- Back to Details
First PageDocument Content
Tyrosine kinase receptors / Peptidase / Clinical medicine / Cancer / Medicine / Oncogenes / Tyrosine kinases / HER2/neu / Cathepsin B / Epidermal growth factor receptor / ErbB / Cathepsin Z
Date: 2016-03-02 01:55:24
Tyrosine kinase receptors
Peptidase
Clinical medicine
Cancer
Medicine
Oncogenes
Tyrosine kinases
HER2/neu
Cathepsin B
Epidermal growth factor receptor
ErbB
Cathepsin Z

Abstract ErbB2 overexpression gives rise to a highly invasive, aggressive phenotype associated with an enlarged lysosomal compartment and increased activity of the lysosomal proteases, cysteine cathepsins. We have recent

Add to Reading List

Source URL: www.cancer.dk

Download Document from Source Website

File Size: 88,02 KB

Share Document on Facebook

Similar Documents

37 | P a g e  Association between age at presentation and pathological features of breast cancer and its effect on survival; a comparative study done in Sri Lanka

37 | P a g e Association between age at presentation and pathological features of breast cancer and its effect on survival; a comparative study done in Sri Lanka

DocID: 1rdIi - View Document

Abstract ErbB2 overexpression gives rise to a highly invasive, aggressive phenotype associated with an enlarged lysosomal compartment and increased activity of the lysosomal proteases, cysteine cathepsins. We have recent

Abstract ErbB2 overexpression gives rise to a highly invasive, aggressive phenotype associated with an enlarged lysosomal compartment and increased activity of the lysosomal proteases, cysteine cathepsins. We have recent

DocID: 1rdcC - View Document

Phase 1b study of WNT inhibitor vantictumab (VAN, human monoclonal antibody) with st rd paclitaxel (P) in patients (pts) with 1 - to 3 -line metastatic HER2-negative breast cancer (BC) Monica Mita,1 Carlos Becerra,2 Dona

Phase 1b study of WNT inhibitor vantictumab (VAN, human monoclonal antibody) with st rd paclitaxel (P) in patients (pts) with 1 - to 3 -line metastatic HER2-negative breast cancer (BC) Monica Mita,1 Carlos Becerra,2 Dona

DocID: 1pnOU - View Document

CURRICULUM VITAE  1. Name: SHAO-CHUN WANG Title and Affiliation: Investigator and Deputy Director China Medical University Hospital

CURRICULUM VITAE 1. Name: SHAO-CHUN WANG Title and Affiliation: Investigator and Deputy Director China Medical University Hospital

DocID: 1pi0O - View Document

EDITORIAL STAFF  From the Editor Debu Tripathy, MD Editor-in-Chief

EDITORIAL STAFF From the Editor Debu Tripathy, MD Editor-in-Chief

DocID: 1oyvT - View Document